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Introduction {#sec005}
============

Transcriptional regulation of genes is one of the key points for gene expression in general. *Cis*-regulatory elements are regions of non-coding DNA that regulate the transcription of neighbouring genes and, among others, serve as a binding site for *trans*-factors. These elements form complex systems. By regulating these complex systems of thousands of genes the morphological maturation of cells as well as their differentiated function are made possible \[[@pone.0235530.ref001]\]. The understanding of these genomic *cis*-regulatory networks is therefore of great significance. There are examples of mutations of *cis*-regulatory promoter regions leading to severe diseases \[[@pone.0235530.ref002]\]. An example of a gene and its regulation that has been focused on by numerous research initiatives for many years is the human *renin* (*REN*). *REN* is considered to be a key enzyme in the renin-angiotensin-aldosterone system (RAAS). RAAS is a vital system of the human body, as it maintains plasma sodium concentration, arterial blood pressure and extracellular volume \[[@pone.0235530.ref003]\]. Abnormal activation of the RAAS can contribute to the development of hypertension, cardiac hypertrophy, and heart failure \[[@pone.0235530.ref004], [@pone.0235530.ref005]\]. According to the WHO about 1.13 billion people worldwide have hypertension which is one of the major causes of premature death \[[@pone.0235530.ref006]\]. Hence, the understanding of transcriptional regulation is potentially important to understand basic principles of many cardio-vascular diseases. Although the main effector molecule of RAAS is angiotensin II (ANG II), the regulation of ANG II and its precursors is mainly regulated by the expression of *REN* \[[@pone.0235530.ref007]\].

Important *cis*-regulatory elements could already be identified for *REN*. Most of the information about those elements could be obtained by cell culture experiments using classical reporter assays or experiments with transgenic mice \[[@pone.0235530.ref008], [@pone.0235530.ref009]\]. To perform classical reporter assays, restriction pieces of the DNA region under investigation are cloned in vectors. The sequences are followed by downstream reporter genes such as *green fluorescent protein* (GFP) or *Luciferase*, whose expression levels can be quantified in different ways. After transfection of the vectors in cells, the activity of the promoter region can subsequently be deduced from the expression level of the reporter genes. However, the DNA sequences in question, e.g. the promoter regions are detached from their endogenous context \[[@pone.0235530.ref010]--[@pone.0235530.ref015]\]. Thus, the experiments must be performed outside the natural environment of the promoter. Furthermore, classical promoter studies assume an independent effect of *cis*-regulatory regions which is reflected in their experimental setup. In conclusion, it is not possible to study complex interactions of individual regulatory elements.

Focusing on human renin, a "*renin* enhancer" (about -12.000 base pairs (bp) to transcription start site (TSS)) as part of an evolutionary conserved region (hRENc region), which is considered to be important for basal *REN* expression \[[@pone.0235530.ref011], [@pone.0235530.ref016], [@pone.0235530.ref017]\]; and more proximally, a "chorion enhancer" (about -5,500 bp to TSS) was found. However, its relevance is still unclear \[[@pone.0235530.ref018]\].

The closest known regulatory region to transcriptional initiation is the proximal *renin* promoter, which has been shown to play a significant role in tissue and cell specificity of *REN* expression following experiments on transgenic mice \[[@pone.0235530.ref017], [@pone.0235530.ref019]\]. Research on the As4.1 cell line has identified a proximal promoter region of the murine *Ren-1C*, for which a position in the human *REN* is usually indicated at about -200 to +6 upstream of the transcription start site \[[@pone.0235530.ref008]--[@pone.0235530.ref010]\]. This region shows distinctive homologies between mice and humans up to a fully conserved TATA box \[[@pone.0235530.ref008]\]. It´s considered to be essential for tissue-specific expression of *REN*, even though the proximal promoter region has reached only a slight enhancement of *REN* expression in murine reporter assays \[[@pone.0235530.ref011], [@pone.0235530.ref014]\]. However, the renal enhancer of *REN* has a lower *trans*-activating capacity compared to the murine renal enhancer \[[@pone.0235530.ref020]\], which could enhance the influence of the proximal promoter in the *REN*.

Reporter studies and Electrophoretic Mobility-Shift Assays (EMSA) have identified numerous transcription factor binding sites for the proximal promoter region. So, there is e.g. evidence for binding sites that are important for gene regulation of *REN* via the second messenger cAMP \[[@pone.0235530.ref021]--[@pone.0235530.ref023]\]. Thus, regulatory elements were also found, whose relevance to transcriptional regulation of *REN* seems to be questionable \[[@pone.0235530.ref024]--[@pone.0235530.ref026]\].

In addition to the *cis*-regulatory elements, the transcription factors (TFs) are essential to enable gene transcription. These proteins bind to DNA and can activate or repress the transcription of genes. There are differences in the way TFs act to regulate gene expression. Some TFs need to assemble with other proteins, others can directly recruit RNA polymerase which then leads to gene transcription \[[@pone.0235530.ref027]\]. In a current review, a distinction is made between approx. 1600 human TFs, which represent \~8% of all human genes \[[@pone.0235530.ref028]\]. There are several ways to classify TFs. In general, a division into basal or general TFs and specific TFs is possible. Basal TFs are ubiquitous in all cells and necessary for transcription to occur \[[@pone.0235530.ref029]\]. During assembly they are part of the preinitiation complex that enables the binding of the RNA polymerase and thus the initiation of the transcription via specific DNA binding sites such as TATA boxes \[[@pone.0235530.ref029], [@pone.0235530.ref030]\]. In contrast, specific TFs only show activity in specific tissues and/or at specific developmental stages. They may bind at specific DNA binding sites (*cis*-regulatory regions), e.g. promoters, enhancers or silencers and are necessary for the regulation of central mechanisms such as cell development or the response to stimuli via signal cascades \[[@pone.0235530.ref031], [@pone.0235530.ref032]\].

A novel experimental approach to explore and thus better understand the complex mechanisms of transcriptional regulation via *cis*-regulatory elements has become possible through further development of the CRISPR-Cas9 system.

This system has become a powerful gene editing engine. It facilitated and expanded the possibilities of loss-of-function and also gain-of-function studies and should even be highly valuable for studying circadian rhythms \[[@pone.0235530.ref033]\].

Apart from gene editing the guided binding of the Cas9-RNA-DNA complex can be used for other purposes. This includes gene activation, gene silencing and gene labelling, for example with fluorescent proteins. In this study we used a modified Cas9 system that is able to activate genes. Therefore, a non-cutting Cas9, that was fused to an activation transcription factor complex was chosen. We used this system to explore the *cis*-regulatory importance of genomic DNA, in this study for the proximal *renin* promoter.

In detail, we used the Synergistic activation mediator complex (SAM) \[[@pone.0235530.ref034]\] ([Fig 1](#pone.0235530.g001){ref-type="fig"}).

![Programmable site-specific activation of REN with designed guides A-E.\
After assembling of the activation complex (SAM) the attaching guide (shown here by the example of guide E) leads the complex to its specific region of the proximal renin promoter (E'). Thus, the guides enable site specific programming of the SAM complex. The resulting gene activation can be measured by a tagged firefly luciferase.](pone.0235530.g001){#pone.0235530.g001}

In 2015, Konermann et al. presented a modified Cas9 (dCas9) that was coupled to a complex of different transcription factors, allowing them to establish a highly efficient guide-RNA-directed *trans*-activating complex referred to as SAM complex \[[@pone.0235530.ref034]--[@pone.0235530.ref038]\]. The dCas9 lost its originally cutting function through mutations in its catalytic domain, making it an efficient DNA-binding protein \[[@pone.0235530.ref039]\]. Additionally, it is coupled to the transcription factor VP64 \[[@pone.0235530.ref040], [@pone.0235530.ref041]\]. Regions of the original tracr-RNA were also modified to bind a complex of trans-activating domains of p65 and HSF1 \[[@pone.0235530.ref034]\]. The dCas9 can be programmed by a single guide-RNA \[[@pone.0235530.ref039]\]. Regarding the design of the guide-RNA it is possible to target any sequence in the genome, given that a PAM site (NGG) follows the 20 nt sequence. In order to make the interactions specific, the sequence should be unique for the given species. This is incorporated by the bioinformatic tools for designing potential target sequences.

The development of this new gene editing tool enables the study of genes and their regulatory elements in their endogenous context and in their natural environment. This kind of research is not possible by classical reporter studies (as described above). In addition, this specific and constant *trans*-factor complex allows the isolated study of the *cis*-regulatory regions since the same trans-factors always bind to the regulatory elements.

In order to obtain more understanding about the complex transcriptional network, mathematical modelling of experimental data was performed. For example, conforming principles have been identified, under which individual sections of a *cis*-regulatory element approximately 14 kb upstream of *REN* interact with each other \[[@pone.0235530.ref042]\]. The possibility of drawing conclusions concerning the dynamics of *cis*-regulatory elements by using mathematical modelling was already shown in 2003 in a study on the *Escherichia coli* bacterium \[[@pone.0235530.ref043]\]. In addition, by mathematical modelling in 1998, complex processes at an important promoter region of *Endo1* had been revealed, which are of great importance for the embryonic development of sea urchins \[[@pone.0235530.ref001]\]. Thus, mathematical modelling can help to deepen the understanding of the complex transcriptional network.

When statistically examining factors that influence a variable, it is of general scientific interest to find out whether these factors act independently or interdependently. In our opinion, this question of complex interactions was given too little importance in the research on *cis*-regulatory regions of *REN*, especially on the proximal promoter \[[@pone.0235530.ref009], [@pone.0235530.ref026]\]. A study that attempted to address this problem with a modelling approach emerged in 2007 \[[@pone.0235530.ref042]\]. However, even here the experiments were plasmid-based and therefore outside of the endogenous context. In addition, a regulatory region of *REN* was in the focus, which is approximately 14.000 base pairs upstream of the start of transcription.

With this study on the one hand we want to show a novel approach to investigate interactions of *cis*-regulatory regions in an endogenous context, and on the other hand raise awareness of how important these interactions are for the understanding of the complex transcriptional network.

To study possible complex interactions within the proximal promoter region of *REN* we applied a novel combined approach. Firstly, this approach consists of combinatorial transfections from five selected guide-RNAs that translocate the SAM-complex to a specific region of the endogenous proximal promoter. The resulting expression levels of *REN* through the different combinations of the targeted promoter regions can be quantified by luciferase activity. Secondly, we generated and fitted two different mathematical models to our experimental data. When modelling experimental data, the principle of simplicity should always be considered. The simplest assumption would be that the regions examined influence the expression of *REN* completely independent of each other. This is reflected in our first model ([sum model]{.ul}). The sum model describes an independent relationship of the promoter sequences we examined to their influence on the activation of *REN*. In this model each individual region is analysed in respect to its influence on gene expression. This approach is comparable to the knowledge that classical promoter studies can provide, since, as described above, these do not allow the possibility of studying complex interactions. However, an important scientific question in modelling is whether a statistical interaction exists \[[@pone.0235530.ref044]\]. In order to address this issue, a second mathematical model was generated ([interaction model]{.ul}). This model represents a more complex assumption of the conditions in the region of the proximal promoter. The interaction model moreover allows interactions between the selected promoter regions to explain the *REN* activation. Regarding modelling we used the multiple linear regression model to fit the linear parameters, which is a standard statistical method \[[@pone.0235530.ref045]\]. In order to check which of the generated models can explain the measured data best, the respective absolute prediction error was calculated. Following the principle of maximum parsimony in modelling, the respective Akaike information criterion (AIC) was calculated for further model judging \[[@pone.0235530.ref046]\]. The objective of this study was to examine potential interactions of sequences within the proximal *renin* promoter. Through combinatorial transfections of specific guide-RNAs using the SAM complex and computational modelling of the measured data we want to show a novel combined approach that helps to enlighten the complexity of *cis*-regulatory regions in an endogenous context. We want to show that transcriptional regulation is even more complex than already known and that complex interactions should be considered when assessing the importance of specific *cis*-regulatory elements. The region of the proximal *renin* promoter is in the focus of this work. Thus, this study may help to better understand the transcriptional regulation of the key enzyme of RAAS. Furthermore, in our opinion this approach is also suitable for evaluating interactions and dynamics of other *cis*-regulatory regions.

Material and methods {#sec006}
====================

Cell line {#sec007}
---------

Human embryonic kidney cells (HEK293) were cultured in T75 cell culture flasks in high-glucose DMEM (Thermo) supplemented with 10% fetal bovine serum (FBS) (Biochrom) and 1% penicillin/streptomycin (Biochrom) at 37°C and 5% CO~2~ in a humidified incubator. The medium was changed every 3--4 days. At approximately 90% confluence, the cells were passaged at a 1: 5 dilution and seeded in a new T75 flask.

Generating SAM-complex expressing cells by lentiviral transduction {#sec008}
------------------------------------------------------------------

24 hours prior to transfection, 1.4\*10^6^ cells were seeded into cell culture dishes (60 mm diameter) in 3 ml high-glucose DMEM supplemented with 10% fetal bovine serum. Transfection was performed at a confluency of 80--90%. Per dish 2 μg of either lenti dCAS-VP64_Blast (Addgene \#61425) or lenti MS2-P65-HSF1_Hygro (Addgene \#61426) \[[@pone.0235530.ref034]\], and the lentiviral packaging plasmids 2 μg pMDLg/PRRE (Addgene \#12251) \[[@pone.0235530.ref047]\], 0.4 μg pRSVrev (Addgene \#12253) \[[@pone.0235530.ref047]\] and pMD2.G (Addgene \#12259) were diluted in BES-buffer (50 mM BES, 280 mM NaCl, 1.5 mM Na~2~HPO~4~ x 2 H~2~O, pH 6.95). CaCl~2~ was added to a final concentration of 0.125 M, the plasmids were incubated for 10 minutes at room temperature and added to the cells. Post transfection (12--16 hours later), the medium was changed to fresh DMEM with 10% FBS. Lentivirus-containing supernatant was harvested 48 hours after transfection. The supernatant was filtered sterile with a 0.45 μm cellulose acetate filter (Roth) and stored at -80°C.

Approximately 50.000 HEK293 cells were seeded per well of a 24-well plate in 500 μl high-glucose DMEM supplemented with 10% fetal bovine serum. The medium was changed to 500 μl of lentivirus supernatant after 12 and 18 hours. First, cells were generated expressing dCas9-VP64; afterwards, MS2-P65-HSF1 were selected with 10 μgml^-1^ blasticidin (Invivogen) and 100 μgml^-1^ hygromycin B (Invitrogen). Cells are now referred to as HEK dCas9-SAM.

Tagging of *REN* {#sec009}
----------------

*REN* was tagged in frame with the gene for firefly luciferase ([Fig 1](#pone.0235530.g001){ref-type="fig"}) and the G418 resistance using a Cas9 and a specially designed guide-RNA `GGCTTCGCCTTGGCCCGCTG`. The G418 resistance cassette was not used in this study but was cloned for potential further experiments with those cells or plasmids. The guide design was performed by the guide design tool "crispr.mit.edu" and cloned according to the manufacturer's instructions into pGuide-it-tdTomato (Clontech). The stop codon was deleted. Luciferase and G418 resistance were linked to the *REN* via T2A and P2A sequences. The flanking homology arms were amplified from genomic DNA of HEK293 cells by PCR. The following primers were used for the reaction:

Renin-left-arm-forward-NotI `GTACGCGGCCGCCGCTCACCAGCGCGGACTATGTAT`,

Renin-left-arm-reverse-PacI `AGCTTTAATTAAGCGGGCCAAGGCGAAGCCAATGCG`,

Renin-right-arm-forward-AarI `acgtccacctgcgtgcttaaaggccctctgccacccaggcag`,

Renin-right-arm-reverse-AscI `AGCTGGCGCGCCGACCCAAGTCAGACGGGCTGGGTTC`.

The homology arm PCR products were integrated into MV-PGK-Puro-TK vector (Transposagen), which was modified by integrating a cassette via NheI and HindIII digestion. The cassette contains a P2A-linker-firefly luciferase-T2A linker-G418 resistance-PGK promotor-puromycin resistance-T2A linker-thymidine kinase ([S1 Fig](#pone.0235530.s001){ref-type="supplementary-material"}) and is flanked by restriction sites NotI and PacI for left homology arm integration and AarI and AscI for right homology arm integration.

For transfection of the plasmids 1.2\*10^6^ HEK dCas9-SAM were seeded into a well of a 6-well plate and transfected 12--16 hours later at a confluency of 80--90%. 1.5 μg of *REN*-tagging donor plasmid and 1.5 μg of pGuide-it-tdTomato vector with the integrated *REN*-guide were diluted in 100 μl Opti-MEM^™^ (Thermo) and mixed with 100 μl Opti-MEM^™^ including 12 μl Lipofectamine ^®^ 2000 (Thermo). After 5 minutes incubation at room temperature, the plasmid was added dropwise to the cells. Cells were selected with 2 μgml^-1^ puromycin. The cells are now referred to as HEK dCas9-SAM_Renin-luciferase.

*REN-guides*: Design and cloning {#sec010}
--------------------------------

The guides used for this work were designed using the online "SAM sgRNA design tool" \[[@pone.0235530.ref048]\] in the beginning of 2018. The guides are sorted in order of specificity (highest to lowest) based on a method described by Hsu et al in 2014 \[[@pone.0235530.ref049]\]. We have chosen the top 5 hits for human *REN* for our experimental approach. The respective 20-base-long promoter sections A' to E' are approximately evenly distributed from 60 to 159 base pairs upstream of the transcription start of *REN* ([Table 1](#pone.0235530.t001){ref-type="table"}).

10.1371/journal.pone.0235530.t001

###### Chosen guides A to E for combinatorial transfections.

![](pone.0235530.t001){#pone.0235530.t001g}

  Guide   Sequence (5'-3')         Distance to TSS
  ------- ------------------------ -----------------
  A       `TCTGCCCTGATTTATTACCC`   -60 bis -80
  B       `ACTGCCCTGCCATCTACCCC`   -81 bis -101
  C       `TCTCACTGCGGGACAGAGCT`   -111 bis -131
  D       `GTGAAGGGTACCCAGGTTTC`   -137 bis -157
  E       `CAGCCCCTCTGCTCCCCATC`   -159 bis -179

Here the five chosen guides A to E with their respective distance to TSS are shown that are used for the experimental work. For guide-design we have used the online "SAM sgRNA design tool" in the beginning of 2018.

The DNA oligos were designed with overhangs for BbsI and cloned into backbone plasmid sgRNA (MS2) ordered from Addgene (\#61424) \[[@pone.0235530.ref034]\] following the depositor's advice. Thus, guides A-E were created.

Transfection of the guides {#sec011}
--------------------------

Approximately 50,000 HEK_dCas9-SAM_Renin-luciferase cells were seeded per well in 96-well plates in 140 μl each of high-glucose DMEM containing 10% FBS, 1% Pen/Strep, 1 mM L-Glutamin (Biochrom), 10 mM HEPES (Thermo) and 250 μM Luciferin D (Promega). The cells were incubated overnight in a cabinet humidified incubator at 37°C and 5% CO~2~. After 16 hours, the transfection with the guides was carried out at a confluence of about 80%. The transfection was performed according to the protocol of Lipofectamine^®^ 2000 reagent. 0.5 μl Lipofectamine^®^ 2000 and a constant amount of guide-DNA per guide and per well were added in a total volume of 10 μl Opti-MEM^™^.

To study whether interactions between the investigated promoter sequences occur all possible combinations of the five guides A-E were transfected into the HEK_dCas9-SAM_Renin-luciferase cells. In each case 30 ng of guide-DNA per guide and per well were used, which means the total amount of DNA per well varied from 0 ng-- 150 ng. Each possible combination was transfected with a sample size of n = 6. We have not performed a concentration dependent analysis for each individual guide in this study. From other studies of other genes in our lab we have used similar concentrations for transfection of guide-RNAs that showed biologically relevant expression of RNA and protein. For this reason, we always used the concentration of 30 ng guide-RNA per well for transfection in the combinatorial setup.

In order to sort the combinations, a binary code was applied so that each combination could be uniquely assigned ([Table 2](#pone.0235530.t002){ref-type="table"}).

10.1371/journal.pone.0235530.t002

###### Pattern of the combinatorial transfections of the designed guides A-E.

![](pone.0235530.t002){#pone.0235530.t002g}

           A   B   C   D   E
  -------- --- --- --- --- ---
  **1**                    
  **2**                    X
  **3**                X   
  **4**                X   X
  **5**            X       
  **6**            X       X
  **7**            X   X   
  **8**            X   X   X
  **9**        X           
  **10**       X           X
  **11**       X       X   
  **12**       X       X   X
  **13**       X   X       
  **14**       X   X       X
  **15**       X   X   X   
  **16**       X   X   X   X
  **17**   X               
  **18**   X               X
  **19**   X           X   
  **20**   X           X   X
  **21**   X       X       
  **22**   X       X       X
  **23**   X       X   X   
  **24**   X       X   X   X
  **25**   X   X           
  **26**   X   X           X
  **27**   X   X       X   
  **28**   X   X       X   X
  **29**   X   X   X       
  **30**   X   X   X       X
  **31**   X   X   X   X   
  **32**   X   X   X   X   X

All performed combinatorial transfections of the designed guides A-E. To sort the combinations, a binary code was applied so that each combination could be uniquely assigned.

Luciferase-reporter-assay {#sec012}
-------------------------

The luciferase assays were performed with HEK_dCas9-SAM_Renin-luciferase cells. The cells were transfected with all possible combinations of the five guides as described above. The sample size of each combination was n = 6. Immediately after transfection, the 96-well plates were sealed and the luciferase activity was measured over time at 37°C in the TopCount^®^ NXT (Perkin Elmer, Waltham, USA). Luciferase activity is expressed in counts per second (cps).

Modelling of received data and statistics {#sec013}
-----------------------------------------

In order to find conforming patterns by which the promoter regions influence the expression of *REN*, models were generated with \"R\". The first model ([sum model]{.ul}) describes an independent relationship of the five selected promoter sequences A'-E' with respect to their influence on the activation of *REN*. This model was chosen because it describes the simplest possible form of framework of the regulatory elements. In this model each individual region is analysed concerning its influence on gene expression. For the independent sum model, the measured activity *y*~*i*~ can be represented by formula 1: $$y_{i} = \in_{i} + \beta_{0} + A_{i}\beta_{1} + B_{i}\beta_{2} + C_{i}\beta_{3} + D_{i}\beta_{4} + E_{i}\beta_{5}$$ where *β*~0~ is the offset, *β*~1...5~ are the linear coefficients, *A*~*i*~...*E*~*i*~ are {0,1} depending on presence in experiment *i* and ∈~*i*~ is the error.

Furthermore, a second model has been generated ([interaction model)]{.ul} that additionally allows interactions between the promoter sequences in order to explain *REN* activation. For the interaction model the measured activity *y*~*i*~ for all the 32 possible combinations can be represented by formula 2: $$\text{y}_{\text{i}} = \in_{i} + \beta_{0} + \beta_{1}A_{i} + \beta_{2}B_{i} + \beta_{3}C_{i} + \beta_{4}D_{i} + \beta_{5}E_{i} + \beta_{6}A_{i}B_{i} + \beta_{7}A_{i}C_{i} + \beta_{8}B_{i}C_{i} + \beta_{9}A_{i}D_{i} + \beta_{10}B_{i}D_{i} + \beta_{11}C_{i}D_{i} + \beta_{12}A_{i}E_{i} + \beta_{13}B_{i}E_{i} + \beta_{14}C_{i}E_{i} + \beta_{15}D_{i}E_{i} + \beta_{16}A_{i}B_{i}C_{i} + \beta_{17}A_{i}B_{i}D_{i} + \beta_{18}A_{i}C_{i}D_{i} + \beta_{19}B_{i}C_{i}D_{i} + \beta_{20}A_{i}B_{i}E_{i} + \beta_{21}A_{i}C_{i}E_{i} + \beta_{22}B_{i}C_{i}E_{i} + \beta_{23}A_{i}D_{i}E_{i} + \beta_{24}B_{i}D_{i}E_{i} + \beta_{25}C_{i}D_{i}E_{i} + \beta_{26}A_{i}B_{i}C_{i}D_{i} + \beta_{27}A_{i}B_{i}C_{i}E_{i} + \beta_{28}A_{i}B_{i}D_{i}E_{i} + \beta_{29}A_{i}C_{i}D_{i}E_{i} + \beta_{30}B_{i}C_{i}D_{i}E_{i} + \beta_{31}A_{i}B_{i}C_{i}D_{i}E_{i}$$ where *β*~0~ is the offset, *β*~1...31~ are the linear coefficients, *A*~*i*~...*E*~*i*~ are {0,1} depending on presence in experiment *i* and ∈~*i*~ is the error.

These models have been fitted with the measured data. For fitting of the models represented in formula 1 and 2 the fitting functionality of the *lm* function of the built-in *stats* package of R version 1.1.423 was used \[[@pone.0235530.ref050]\]. The idea behind this is to minimize the error in prediction of *y* by optimizing the linear factors *β* for the experimental data. The *lm* function of the R package *stats* computes the linear factors *β* that fit the input variables A to E according to the proposed model including all the statistics of the fitted parameters. The complete data that was used including the R-script can be found in the supplementary material ([S1 Table](#pone.0235530.s003){ref-type="supplementary-material"}, [S1 Script](#pone.0235530.s004){ref-type="supplementary-material"}). Data was analysed at 60 hours after transfection.

For the evaluation of the models we used the obtained coefficients of the respective model and put the coefficients in formula 1 and 2, respectively. For statistical analysis of the coefficients itself the built-in p-value calculation of the multiple linear regression of the *lm* function of R was used. For comparison of the models we calculated the respective absolute prediction errors of the two models with the built-in *predict* function of the stats package of R \[[@pone.0235530.ref050]\]. After fitting of the linear factors *β*, the error ∈~*i*~ could be calculated for the experiments *i* through conversion of the respective formula. For statistical analysis of the respective absolute prediction errors we used the independent 2-group Mann-Whitney U Test \[[@pone.0235530.ref050]\]. To compare the generated models following the principle of maximum parsimony in modelling, the *AIC* (Akaike Information Criterion) of each model were calculated for further model judging. The *AIC* was calculated in the R environment with the *AIC* function of the *stats* package \[[@pone.0235530.ref050]\].

Random controls were generated by the built-in *sample* function of R \[[@pone.0235530.ref050]\]. For this purpose, a dataset was created by randomizing the values of the respective variables A to E. This randomized data was then fitted to model 1 and 2. No statistically significant p values for the coefficients were obtained in the random case ([S1 Script](#pone.0235530.s004){ref-type="supplementary-material"}).

The entire statistical evaluation including model fitting and model evaluation by 2-group Mann-Whitney U Test of the respective prediction errors and calculation of the AIC did not need any further parameters, apart from the experimental parameters such as incubation temperature or evaluation at about 60 hours after transfection.

Results {#sec014}
=======

Our aim was to explore possible interactions within the proximal *renin* promoter. Therefore, HEK cells were transfected with all combinations of guides that represent the selected promoter sequences A' to E'. The luciferase signal of transfected HEK dCas9-SAM_Renin-luciferase cells, that indicates renin activation, was measured over time in the TopCount^®^ NXT. With a modified Venn diagram the activation levels of *REN* via all of the 32 resulting possible combinations of the guides were visualised ([Fig 2](#pone.0235530.g002){ref-type="fig"}). The 32 individual areas result from overlaps of the five main areas A-E, which represent the guides. The size of the respective area is of no significance considering the results. The circle area surrounding the entire individual areas reflects the case in which none of the guides were used.

![Visualisation of the 32 possible combinations of guides.\
This modified Venn diagram represents each of the 32 possible combinations of guides as a surface. The individual areas result from overlaps of the five main areas A-E, which represent the guides. The size of the respective area is of no significance considering the results. The circle area surrounding the entire individual areas reflects the case in which none of the guides were used. Three examples are shown here. (I) All combinations including A are filled light grey; (II) All combinations including A and C are filled in dark grey; (III) Combination consisting solely of A and C are marked dark grey.](pone.0235530.g002){#pone.0235530.g002}

Each combination of guide RNAs has its own binary code assigned. Each transfection of HEK dCas9-SAM_Renin-luciferase was done according to the same protocol (see [Material and methods](#sec006){ref-type="sec"}).

After approximately 24 hours of transfection of the combinations of RNA guides to HEK dCas9-SAM_Renin-luciferase, expression of the *REN* could already be detected via the increase in the luciferase activity. Over time, the expression levels differed for the individual combinations of the promoter sequences ([Fig 3](#pone.0235530.g003){ref-type="fig"}). In [Fig 3](#pone.0235530.g003){ref-type="fig"} expression levels of the 32 possible combinations are shown at three different time points after transfection using the modified Venn diagram as described above ([Fig 2](#pone.0235530.g002){ref-type="fig"}). Respective activation levels of *REN* were expressed in a colour ramp that rose in ascending order from white to yellow, further to red and up to blue. For analysis, the values of expression levels were scaled logarithmically. Otherwise, since these values were widely divergent, only a few surfaces would have been coloured in a linear scale, whereas most were white to slightly yellow. On the one hand the individual guides itself caused different levels of renin expression. On the other hand, the different combinations achieved different renin activation ([Fig 3](#pone.0235530.g003){ref-type="fig"} and [S1 Table](#pone.0235530.s003){ref-type="supplementary-material"}). The combinations of the two guides C---B or A---E caused a renin activation that was higher than the simple summation of the respective individual activation levels. In contrast, combinations of the two guides A---B or also D---C have a less increasing effect on the renin activation.

![Visualisation of the luminescence shows the activation of renin via cis-regulatory regions for each individual combination of guides over time.\
The expression levels of the 32 possible combinations are shown here at three different time points after transfection of HEK dCas9-SAM_Renin-luciferase. By translating the luminescence values into a colour scale, the corresponding colour intensity resulted for each RNA guide combination. A time-dependent increase in the expression levels of the 32 guide combinations becomes obvious. Furthermore, individual guides and the 32 possible combinations caused different expression levels of REN. The axis \"Expression\" is scaled logarithmically (each area n = 6).](pone.0235530.g003){#pone.0235530.g003}

To further investigate the potential interactions of the chosen proximal promoter sequences we generated two mathematical models in R and fitted them to the measured data described above.

The first model was the sum model. It describes an independent relationship of the five selected promoter sequences with respect to their influence on activation of *REN*. We chose this model because it assumes the simplest possible correlation between the promoter regions. Modelling of the data revealed that all sequences studied significantly affected the activation of *REN* ([S2 Fig](#pone.0235530.s002){ref-type="supplementary-material"}). However, the assessed values of the 32 combinations often show deviations to the predictions of the sum model ([Fig 4](#pone.0235530.g004){ref-type="fig"}). The measured luminescence values were smaller than the values predicted by the sum model after transfection of all combinations in which neither guide A nor B were involved. As soon as either A or B was present in the combinations, the luciferase activities were higher or at least at the level of the prediction. Exceptions were combinations in which A or B stimulated the expression of the *REN* in each case by solely driving the promoter sequence. Interestingly, when guides A and B were both present in the combinations, values in the range of the prediction or below were measured.

![Luciferase measurements vs. predicted values of the models.\
The measured values (grey) of each combination are plotted with the respective prediction of the **sum model** (blue) and the **interaction model** (red). The measured values show deviations from the predicted values of the **sum model**. The prediction of the **interaction model** better matches the measured expression levels of the 32 different combinations. The luciferase activity is expressed in counts per second (cps). The measured values are presented by their medians. The curves of the measured values result from \>3,000 measuring points per combination (32 combinations, each n = 6).](pone.0235530.g004){#pone.0235530.g004}

The second investigated model, the interaction model, allows interactions existing between the individual promoter regions in order to explain the measured data. The deviations of the predicted values of the interaction model are smaller than the predicted values of the sum model ([Fig 4](#pone.0235530.g004){ref-type="fig"}). Thus, the interaction model seems to better describe the measured expression levels of the 32 different guide combinations.

In the next step we compared the two models. By calculating differences of the measured values against the predicted values of the two models, we were able to visualise the degree of similarity at three chosen time points at [Fig 5](#pone.0235530.g005){ref-type="fig"}. It becomes obvious that an independent relationship of the promoter sequences as assumed in the sum model cannot adequately explain *REN* expression.

![Differences between measured values and predicted values of the models at three different time points.\
The differences of measured values and predicted values of the 32 possible combinations assuming the two generated models are shown here for three different time points after transfection. Areas turn red when the differences between the measured luciferase activity and the predicted values of the respective model are positive and turn blue when the differences are negative. (A) In the sum model over time, the colouration of the combinations increases. (B) For the interaction model almost no colouration can be recognised over time. The values of the differences are linearly scaled (each area n = 6).](pone.0235530.g005){#pone.0235530.g005}

The prediction of the sum model and the measured values differ, as seen at Figs [4](#pone.0235530.g004){ref-type="fig"} and [5](#pone.0235530.g005){ref-type="fig"}. This motivated us to further analyse the better fitting interaction model. The influences of the linear single factors A to E are no longer significant (with exception of B) when interaction of the sequences is allowed ([Fig 6](#pone.0235530.g006){ref-type="fig"}). The activities of the combinations A---C, A---D, A---E, B---C, B---D, B---E significantly outweighed those linear single factors. These results underline that interactions within the promoter regions are essential for the extent of the assessed gene activity.

![Influence of the promoter regions (A to E) and their potential interactions on gene activity of REN.\
The strength of influence of certain combinations of promoter sequences outweighs the influences of the singular linear individual factors. Influences of linear single factors A-E are no longer significant, with exception of B. Significances resulted from the multiple linear regression modelling with the lm function of the build in stats package in R. Strength of influence is represented as arbitrary unit (a.u.). (mean and SD, n = 6, p-values: \*\<0.05, \*\*\*\<0.0005).](pone.0235530.g006){#pone.0235530.g006}

Further, for both models, the absolute error (absolute difference between measured and predicted model values) was calculated. The error was significantly smaller for the interaction model than for the sum model (p\<2.2\*10^−16^ according to 2-group Mann-Whitney U Test; [Fig 7](#pone.0235530.g007){ref-type="fig"}). For further comparison, the AIC was calculated for both models. This AIC calculation returned a value of 3881.4 for the sum model and a value of 3609.6 for the interaction model, indicating the interaction model to be statistically more adequate. In order to check whether these results could have been a coincidence, all measurement data of the individual promoter sequences were randomised. After applying the generated models to this randomised data, no significant effects on the expression of *REN* were found for the selected promoter sequences ([S1 Script](#pone.0235530.s004){ref-type="supplementary-material"}).

![Distribution of the respective absolute error of the sum model vs. the interaction model.\
Here, the two models are compared by calculation of their respective absolute prediction errors. The distribution of the absolute errors is shown as a box plot. The absolute prediction error of the interaction model is significantly smaller than that of the sum model (p\<2.2\*10^−16^ according to 2-group Mann-Whitney U Test). Absolute error is represented as arbitrary unit (a.u.).](pone.0235530.g007){#pone.0235530.g007}

Discussion {#sec015}
==========

In a combined approach, consisting of combinatorial transfections and computational modelling of the measured data we analysed the role of *cis*-regulatory elements in the proximal promoter of human *REN*. According to research on murine *Ren-1C* via reporter assays, the proximal *renin* promoter is described to have low activation potential for the *REN* \[[@pone.0235530.ref011], [@pone.0235530.ref014]\]. However, compared to the murine renal enhancer the gene activating capacity of human renal enhancer is lower \[[@pone.0235530.ref020]\], which could enhance the influence of the proximal promoter in the *REN*. Furthermore, a 99% decrease in the transcriptional activity of renin was also found when the region of the proximal promoter was deleted in reporter assays performed in As4.1 cells \[[@pone.0235530.ref026]\].

However, in our experimental setup the *REN* expression could be triggered by the targeted translocation of the SAM complexes to all five promoter sequences ([Fig 3](#pone.0235530.g003){ref-type="fig"}, [S2 Fig](#pone.0235530.s002){ref-type="supplementary-material"}).

The combinatorial transfections were performed with a constant amount of guide-DNA per guide. In a previously unpublished study, we have determined renin levels after activation of this promoter region. We were able to show that the catalytic activity of renin was present in the supernatant of the HEK cells. This shows that we operate in a biological sensible range of renin expression. Further it shows that secreted renin (biologically relevant for blood pressure regulation) was produced in our cells.

Our new approach includes computational modelling of the measured data besides the combinatorial transfections. This enabled deeper insights into *cis*-regulatory interactions. Independent linear models are a method to describe multifactorial influences on an output variable (in this case renin transcription). In the simplest case this would be a two-factor setup, e.g. whether a drug (factor 1) acts dependent on sex (factor 2). An example of a linear sum model would be the calculation of the melting temperature (*T*~*m*~) of the DNA:*T*~*m*~ = 4(*G* + *C*) + 2(*A* + *T*). A more advanced and complex formula that considers the neighbouring relationships of the base pairs was described by [Hooyberghs](http://apps.webofknowledge.com/OutboundService.do?SID=E14E7MVLOCQ2StQ6urX&mode=rrcAuthorRecordService&action=go&product=WOS&daisIds=737206) et al. in 2009 \[[@pone.0235530.ref051]\].

Considering the independent **sum model**, guide A reached the most potent effect. The homologous region coincides with a well conserved sequence in mice and humans and is considered to be an important sequence for responding to cAMP stimulation within the proximal *renin* promoter \[[@pone.0235530.ref021]\]. cAMP is known to be an important transcription factor for stimulating *REN* transcription \[[@pone.0235530.ref005], [@pone.0235530.ref009]\].

So far, we can state that the examined promoter regions seem to have different degrees of influence on gene expression of *REN*. The different measured expression levels of the individual transfections can depend not only on the possible different activation ability but also on other factors that were not considered in this work. For example, the regions examined can be occupied by other TFs. A special secondary structure of the DNA or the arrangement of the nucleosomes might also make the access to the SAM complex more difficult \[[@pone.0235530.ref052]\]. However, this gain in knowledge would probably also have been possible with classical reporter assays. Most of the knowledge about the importance of *cis*-regulatory areas of the *REN* is based on this type of promoter studies \[[@pone.0235530.ref008], [@pone.0235530.ref009]\].

However, whether there are interactions within *cis*-regulatory regions should be a central question in the research of the complex transcriptional network \[[@pone.0235530.ref044]\]. In particular, if one looks at the proximal promoter of *REN*, in our opinion, the question about the existence of complex interactions and whether these may have significance for the interpretation of *cis*-regulatory elements was given too little attention \[[@pone.0235530.ref009], [@pone.0235530.ref026]\]. Due to the experimental setup, the ability to explore these dynamics is a limitation for classical promoter assays. With our approach, however, this question could be examined.

To address this issue, we enabled more complexity to explain the measured expression levels. The next level of complexity would include---apart from the linear scaling factors--those factors describing statistical interaction. Therefore, an **interaction model** was subsequently computed and fitted to the measured data. Looking at the interaction model we could see the importance of interaction ([Fig 6](#pone.0235530.g006){ref-type="fig"}). By allowing interactions of the promoter regions the influences of the linear single factors A to E were no longer significant (with exception of B). Certain sequence interactions significantly outweighed the independent relationship which is assumed by the sum model. This gain of knowledge is one of the major benefits of this combined approach. When interpreting the importance of certain *cis*-regulatory elements, dependencies and interactions between neighbouring *cis*-regulatory elements should be considered. For example, according to our results region A seems to be important for *REN* activation especially in combination with the neighbouring sequences C, D or E. This would mean that if one analyses the role of a native transcription factor targeting region A the other regions need to be considered in this analysis as well.

By tagging the native *REN* with the reporter *firefly luciferase*, the *REN* expression could be analysed in its natural position in the human genome. This is another great advantage over classical reporter studies, as they do not allow investigation in an endogenous context \[[@pone.0235530.ref010]--[@pone.0235530.ref015]\]. To our knowledge such a combined approach of experimental research of *cis*-regulatory importance and possible statistical interaction by means of a modified Cas9-system and subsequent computational modelling has not been performed before. The only study known to us that attempted to elucidate the complexity of a *cis*-regulatory element of renin using a modelling approach has been published in 2007 by Mrowka et. al. However, the endogenous context was not considered in that study \[[@pone.0235530.ref042]\]. Another advantage of this approach is the induction of gene expression by the used trans-activation complex SAM \[[@pone.0235530.ref034]\]. This is because the TFs of this complex are always the same. Therefore, any variations in the diversity of transcription result from the *cis*-regions. For instance, if one would use two different transcription factors with two different *cis*-regulatory regions it would not be possible to make a statement about *cis*-regulatory interaction of the region in question.

Of course, each of the generated models have advantages and disadvantages. The sum model is based on fewer parameters than the interaction model. More parameters increase the risk of overfitting of a selected linear model, which is why the sum model has advantages here. When looking at the calculated prediction error, the interaction model shows a smaller value. This fact can also be attributed to the higher number of parameters which the interaction model is based on. Another possibility of comparing the models is the AIC. The AIC is a common criterion for the evaluation of different linear models of the same dataset. On the one hand, it rewards the goodness of fit (likelihood function), but it also contains a penalty term, which penalises too high model complexity. This corresponds to an evaluation based on the principle of maximum parsimony. With an increase in model complexity, the goodness of the fit usually gains as well (risk of overfitting). But the calculated AIC was also smaller for the interaction model. Another big advantage of this approach is that the entire statistical evaluation in the form of model fitting and model evaluation by 2-group Mann-Whitney U Test of the respective prediction errors and calculation of the AIC did not need any further parameters. This does not apply to the experimental parameters such as incubation temperature or the determination of the timepoint of approximately 60 hours after transfection for the modelling approach.

In conclusion, we found that the interaction model explains the measured expression levels of *REN* better. Thus, interactions between the individual sequences seem to be necessary to explain the measured activity levels of *REN*. This in turn would mean that interactions between the individual promoter sections are necessary in order to describe the transcription of *REN* via the proximal *renin* promoter. In this study showed that complex interactions occur within the selected *cis* regions of the endogenous proximal promoter of *REN*, which could be relevant for a better understanding of its transcriptional regulation. This novel combined approach of combinatorial transfections and mathematical modelling and the use of a modern Cas9-based trans-activating complex expands the possibility to study the *cis*-regulatory importance of non-coding DNA in an endogenous context. Further, this approach might be potentially useful to examine other genomic regions.

Supporting information {#sec016}
======================

###### Cassette stably integrated into the genome of the HEK dCas9-SAM_Renin-luciferase cells.

The cassette contains the Firefly luciferase, which was used as a reporter for REN expression. Puromycin was used to select the cells. The homology arms were required for the correct in frame insertion of the cassette. The elements G418-resistance and thymidine-kinase also contained in the cassette were not used in this study.

(TIF)

###### 

Click here for additional data file.

###### Strength of influence of the investigated promoter regions based on the sum model.

All investigated sequences significantly affect the activation of REN. Considering the sum model, guide A reached the most potent effect. Significances resulted from the linear regression modelling with the *lm* function of the *stats* package in R. (p-values: \*\<0,05, \*\*\*\<0,0005).

(TIF)

###### 

Click here for additional data file.

###### Luciferase activity for all 32 guide combinations at three different time points.

(DOCX)

###### 

Click here for additional data file.

###### R script source code.

(PDF)

###### 

Click here for additional data file.

###### 

(CSV)

###### 

Click here for additional data file.
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Dear Editor,

thank you for reviewing the submitted article and for the opportunity to submit a revised version of the manuscript. We have answered all the questions that you and the reviewers have raised. In particular we have extended the introduction section and reorganized the results and discussion in order to make it more accessible to a wider range of readers. Further we have improved the graphics and statistical presentation. We have further given more detailed information about the modelling approach and have provided all the R-scripts in the supplement.

All authors declare that we do not have competing interests.

Journal Requirements

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, phrase "data not shown"

According to the journal requirements we have provided all the data such that the phrase "data not shown" was removed completely.

2\. funding information in the Acknowledgments section

We removed the funding information in the Acknowledgments section. You will find the funding information in the Funding Statement section of the online submission form.

3\. Competing interests

We added the statement "The authors have declared that no competing interests exist." in a Competing interests section in our cover letter. 

Review

Comments to the Author

Reviewer \#1:

Dear reviewer,

thank you for reviewing the submitted manuscript. We have thoroughly revised the manuscript according to the points that you have raised and have answered all your questions.

Major comments

Introduction

1\. The function and importance of Renin should be described in the Introduction.

We introduced a paragraph with explanations of renin and the renin-angiotensin-aldosterone system (RAAS) and its importance for the human organism. This was done in the introduction section.

2\. Please give details about the general processes of trans- and cis-transcriptional regulation.

We added a paragraph to give details about general processes of trans- and cis-transcriptional regulation. This can be found in the introduction section.

3\. How does the new trans-activating dCas9-system help analyse cis-activation of the proximal promotor?

We have added the following paragraph that emphasizes the importance of the trans-activating complex:

"Apart from gene editing the guided binding of the Cas9-RNA-DNA complex may be used for other purposes than gene editing. This includes gene activation, gene silencing and gene labeling with fluorescent proteins for example. In this work we used a modified Cas9 system that can be used to activate genes. This makes use of non-cutting Cas9 that was fused to an activation transcription factor. We used this system in order to explore the cis-regulatory importance of genomic DNA. More specifically we use the synergistc activation mediator complex (SAM)...

...The development of this new gene-editing tool enables the study of genes and their regulatory elements in the endogenous context and in the natural environment of the gene. This form of investigation is not possible by classical reporter studies (as described above). In addition, the defined and constant trans-factor complex allows the isolated investigation of the cis-regulatory regions, since the same trans-factors always bind to the regulatory elements."

What are classical reporter studies and how are they done?

We added the following paragraph to give details about that in the introduction:

"Numerous classical reporter studies have enabled the identification of important cis-regulatory elements. In these studies, restriction pieces of investigated DNA, e.g. promoter regions, are cloned into vectors. After transfection of those vectors into cells, activation levels of these promoter regions can be measured via downstream reporter genes, such as green fluorescent protein (GFP) or luciferase. But the investigated DNA, e.g. the promoter regions are removed from their endogenous context. Thus, the experiments must be performed outside of the natural environment of the promoter. This circumstance and the lack of opportunity to study complex interactions of individual regulatory elements are limitations of these classic reporter studies."

4\. What is RAAS and how does it relate to the experiments described in this manuscript?

Thank you for raising this issue. This point was introduced in an extra paragraph in the introduction section.

Materials and Methods:

5\. If I understand correctly, Renin was tagged with a sequence for Geniticin resistance, but cell selection was done with Puromycin. How does this work?

The genome was modified in the following way:

Renin-P2A-luciferase-T2A-G418-PGK promoter-puromycin resistance

In order to select for successful insertion of the insert puromycin may be used. The G418 was introduced to have a potential additional selection marker for selecting renin positive cells in a possible high throughput screening. This G418 resistance cassette was not used in this study.

Therefore, the cloning of G418 resistance has no significance for this work but was cloned for potential further experiments with those cells or plasmids.

The actual selection was performed with puromycin.

6\. The models need more explanation and description: Why were these models chosen?

Independent linear models are reasonable way to describe multifactor influences on output variable (in this case renin transcription). The next level of complexity would include apart from the linear scaling factors, those factors that describe statistical interaction.

How were the models built?

These models have been fitted with the measured data. For the fittings of both linear models the function lm of the package stats in the R version 1.1.423 was used.

Which data was the basis for the models and which data points were used as controls?

The complete data set that we have used is included in the supplement material. Random controls were generated by a section in the R script.

How were the models analyzed? What is the accuracy of your models and how did you compute this value? Is there code available regarding these analyses? How did you do your statistics?

The lm function of the R package stats computes the linear factors that fit the input variables according to the proposed model including all the statistics of the fitted parameters. The full code of the R scripts is provided in the supplement material.

Discussion:

7\. It is shown in your results that guide A has especially good activating ability for Renin. Is the activation level of Renin by guide A comparable to biological activation of Renin? Can you be sure that the activation ability of guide A is representative for all the other guides? Without knowing this basing the concentration of all other guides on guide A seems somehow random to me. What was your reasoning for this? Why not base the concentrations each of the guides on a baseline for each of them? Please answer these questions in the manuscript.

This experiment was only performed to find a sensible dosage for transfection. In order to make this clear we have added this information to the manuscript.

Performing all subsequent experiments with multiple concentrations of the individual guides would have allowed the dimensions of the experiments to grow exponentially. With a repetition factor of 6 which was used in our approach, we would have had to perform 18,750 instead of 192 experiments assuming 4 different concentrations of each guide.

It would have been perhaps interesting to see those results of this extended approach. However, at that scale it was out of our resources.

8\. Is there independent data corroborating the results of the analyses of the models?

This particular region with this specific setup has not been investigated by other groups (to our knowledge). To put this on a more general level it is of interest of studying gene regulation whether or not particular regulatory elements act independently or whether or not those elements show interactions with other regulatory regions.

What are the pros and cons regarding your choice of model? Please discuss this in the manuscript.

sum model: pro: less parameters contra: larger prediction error

interaction model: pro: smaller prediction error contra: more parameters

In order to find the optimum according to the principle of maximal parsimony we used the Akaike Information Criterion (AIC) for judging which model to prefer.

9\. If I understand correctly, each of the guides targets a certain known area of the proximal promotor. Can you formulate hypotheses on how your data and models relate back to these promotor regions and how they interact to lead to the relative expression levels? Are the regions of guides A and B already known to being the most important activators of Renin expression or is this a new discovery?

Thank you for raising this point. As you have suggested we have checked whether or not there are transcription factor binding sites for A and B present or known in the literature. In fact, for region A the so-called cAMP responsive cis element is present which has been investigated to be important for cAMP dependent activation of renin. This fact has been put to the introduction section.

Actually, to me most of the Discussion section seems to belong in the results section as it just describes the results but does not discuss them in biological or other contexts. Please include a discussion of these questions in the revised manuscript.

Thank you for putting up this issue. We have completely revised the discussion section and have shifted all parts that are related to the results to the results section.

Supplement:

10\. Throughout the manuscript there are a few results mentioned without showing the data they are based on. All these experiments and results should be provided in a Supplement file. Also, R code for all model generation and all analyses should be provided as well.

We provide now the following additional data in the supplement section:

\- S1 Fig. Cassette stably integrated into the genome of the HEK dCas9-SAM_Renin-luciferase cells.

\- S2 R-script. "source code"

\- S3 Fig. Strength of influence of the guides based on the sum model.

General:

11\. There are a few grammar, tense and word choice mistakes. Please revise and proofread the manuscript regarding these, especially the Materials and Methods Section. Also, the symbol for micro was not displayed correctly in many places. Many abbreviations throughout the manuscript were either not explained or only explained later in the text - this must be corrected as to the common abbreviation customs. Also, please provide the full names with locations for each of your Materials suppliers and for all substances used and mentioned in the manuscript.

The manuscript has been read by a native speaker in order to correct and avoid possible mistakes.

Minor comments:

12\. Are there variations in the transfection performance when using 7ng of DNA compared to 150ng?

The variations are shown in the error bars of the experiments in Fig 2 which represents standard deviation. The dose response curve was used to find the concentration for a certain activation of renin.

13\. Figure 2: Why does the luciferase activity decrease at higher guide A concentrations? Please mention this in the Figure text.

We mentioned the decrease of luciferase activity in the figure text. The increase in the concentration of the guide DNA above 30 ng per well did not lead to a significant increase in expression, presumably due to saturation phenomenon.

14\. Figure 3: To me, this Figure seemed redundant in many parts. I through IV are never explained in the figure text, the different combinations were already represented in Table 1, and the actual results are represented in Figure 4. I propose the incorporation of parts of Figure 3 into Figure 4 together with its Figure text. Or reduce Figure 3 into its essential parts.

Thank you for raising this point. To follow your suggestion we have reduced the number of examples in Fig 3. The new Fig contains now less instances of combinations. We also changed the color scheme of the figures. This also should address red-green color blindness.

15\. Figure 4: The slight differences in color at time point 60.52h are nearly not visible. Please include numeric values for each combination.

Since the values for expression levels were widely divergent, only a few surfaces would have been colored in a linear scale, whereas most would have remained white. That's why we chose a logarithmic scale for figure 4. We changed the color scheme of the figure in order to better recognize the differences. We did not use a figure with numerical values, as this would have become very confusing.

 

Reviewer \#2:

Dear reviewer \#2,

thank you for reviewing the submitted manuscript. We have thoroughly revised the manuscript according to the points that you have raised and have answered all your questions. First, we want to show a novel approach to investigate cis-regulatory interactions.

Major comments:

• Why did you study the renin promoter? Is it a prominent example of cis-regulation or is there a relationship to a disease?

Renin is the rate limiting step in the renin-angiotensin-aldosterone-system (RAAS), which is important for the long-term regulation of blood pressure. According to WHO high blood pressure for example is one of the major causes of premature death worldwide (<https://www.who.int/news-room/fact-sheets/detail/hypertension>).

Hence understanding of transcriptional regulation is potentially important for understanding basic principles of many cardio-vascular diseases. These points are introduced in a paragraph with explanations of renin and the renin-angiotensin-aldosterone system (RAAS) and its importance for the human organism in the introduction section.

• Laboratory experiments are detailed described, whereas the model setups of the sum model and the interaction model are not described at all. Please go into detail in the methods about the model setup and how simulations were performed based on these models.

Furthermore, describe the performed statistical analyses.

Both models are introduced int the introduction section. For details of the implementation including the statistical analysis we provide the complete R-script in the supplement. The basic ideas of the models including their pros and cons have now been added to the manuscript.

In addition, introduce both kinds of models in the introduction.

Thank you for raising this point. We added a paragraph to the introduction section that describes both models.

What are differences and limitations? How do they work?

We added the following paragraph to the discussion section:

"Independent linear models are a way to describe multifactor influences on output variable (in this case renin transcription) ...

... The next level of complexity would include apart from the linear scaling factors, those factors that describe statistical interaction. Therefore, an interaction model was subsequently computed and fitted to the measured data. The selected models each have advantages and disadvantages. The sum model is based on fewer parameters than the interaction model. More parameters increase the risk of overfitting of a selected linear model, which is why the sum model has advantages here. When looking at the calculated prediction error, the interaction model showed a smaller value. This fact can also be attributed to the higher number of parameters which the interaction model is possibly based on."

• In which context are the models otherwise applied?

An example of a linear sum model would be the calculation of the melting temperature of the DNA:

Tm = 4(G+C) +2(A+T)

And in a more advanced complex form a formula that considers the neighboring relationships of the basepairs:

Hooyberghs, J.; Van Hummelen, P.; Carlon, E. (2009). \"The effects of

mismatches on hybridization in DNA microarrays: Determination of nearest

neighbor parameters\". Nucleic Acids Research. 37 (7): e53.

doi:10.1093/nar/gkp109. PMC 2673445. PMID 19270064

In general the question of independence or interaction is an important question of many multifactor analysis setups in science \[1\].

In the simplest case this would be a two-factor setup, for example whether or not a drug (factor 1) acts dependent on sex (factor 2).

• The results should be described in much greater detail and initial interpretations should be given. Unfortunately, the explanation of the experiments is described in more detail in the discussion than in the actual part of the results.

In order to give more details about the results we have restructured the results and discussion section. Furthermore, we have given more details in Fig 5 describing the original data and the prediction values of both models.

We have modified the captions of the figures in order to enhance the readability.

• In figure 2 you show the molecular ratio of guide A to achieve maximal luciferase activity. Do these concentrations levels also correspond to luciferase activity after transfection with the other guides B-E? If not, what is the explanation?

This dose-response experiment should only determine the concentration under which a certain activation of renin occurs. Performing all subsequent experiments with multiple concentrations of the individual guides would have allowed the dimensions of the experiments to grow exponentially. With a repetition factor of 6 which was used in our approach, we would have had to perform 18,750 instead of 192 experiments assuming 4 different concentrations of each guide.

It would have been perhaps interesting to see those results of this extended approach. However, at that scale it was out of our resources.

• Figure 5 compares the model predicted values in comparison to measured data. But it is not stated which of the two model is compared.

Are there differences between the models? Same question for Figure 6. In addition, the statements in Figures 5 and 6 are almost identical. It should be thought to use only one of the two figures and to present the measured data in a supplement material.

In order to provide better understanding of the models and the data we provide first a time dependent Fig 5 and a cross sectional representation of 3 selected timepoints highlighting the overlapping values in a venn diagram representation. We believe that both figures enhance the understanding of the data and the modeling approach.

Then I would recommend preparing the colored surface depicting luciferase activity for both kinds of model in comparison to real measured data.

Thank you for highlighting this point. We have implemented now your suggestion in Fig 5 and 6.

• In the discussion, the results obtained should be discussed and not described again.

Thank you for raising this point. We have revised the results and discussion section and separated results from discussion more clearly.

• What biological conclusions can be drawn from the experiments and is this assumption supported by other studies? Do the new findings reflect the state of the art?

Understanding of the cis-regulatory role is of general interest. There are examples were mutations of cis-regulatory promoter regions lead to sever diseases \[2\]. Many studies of promoter activity have been done by means of isolated singular promoter fragments that have been cloned in reporter vectors. In our approach we investigate the promoter region in its natural context. This was done by the recently developed modified Cas9/SAM (synergistic activation mediator) complex. We further expanded this to a combinatorial approach. The advantage of using the SAM system is that the trans factors are always the same. Therefore, any variations in the transcription variety must be due to the cis region. If one would for instance use two different transcription factors with two different cis regulatory regions it would not be possible to make a statement about cis-regulatory interaction.

• Which of the two applied models is the best to study promoter activity and why?

Our analysis shows that the interaction model is best to describe the experimental data obtained in our study. First the prediction error is lower and second because we want to obey the principle of maximum parsimony, we have checked the models with the Akaike information criterion (AIC). The AIC is an estimator of out-of-sample prediction error and thereby relative quality of statistical models for a given set of data. Given a collection of models for the data, AIC estimates the quality of each model, relative to each of the other models. Thus, AIC provides a means for model selection.

• What came out of the studies regarding renin promoter activity and how can this be used?

Thank you for raising this issue. For example, region A is important especially in combination with neighboring regions, this would mean if one investigates role of a native transcription factor targeting region A the other regions must be considered in this analysis as well. To make this clearer we have added this interpretation to the discussion.

Minor comments:

• Put only the real manuscript title on the title page and not the short one necessary for PLOS ONE.

We removed the short title from the title page.

• Add the symbol asterisk for the corresponding author.

We added the symbol asterisk for the corresponding author.

• Please refer to the guidelines of PLOS ONE concerning double spaced text, figure references in the text, figure legends and use squared brackets to refer to other publications. See therefore:

Thank you for raising this point. We have revised the manuscript in order to fulfill the guidelines of PLOS ONE.

• English should be improved. Try to use shorter sentences and avoid to many "which's". Do not mix British and American English and replace the decimal place comma by a point.

The manuscript has been read by a native speaker in order to correct and avoid possible mistakes.

• Did the online design tool "crispr.[mit.edu"](http://mit.edu”) suggest you more than the shown five guides A'-E' and if so, why did you chose these five guides?

We have focused the study on the proximal promoter of renin comprising approximately the first 200 bases from transcription start site. In this region we have chosen 5 target regions appr. evenly distributed with the help of the "crispr.[mit.edu"](http://mit.edu”) online tool. Detailed information about sequences and their positions is given in the manuscript.

• Figures should be referenced in the sentence and not after the point.

We avoided to refer figures after the point in the revised manuscript.

• Fig. 3 is another representation of table 1. Where is the benefit of this figure?

Fig. 3 is intended to be a better illustration of the 32 possible combinations and serves to better understand the following Figures 4 and 6.

• Fig. 6: Here I would recommend considering the choice of color in order to take color blindness into account.

We changed the colors of Fig. 3, 4 and 6. This also should address red-green color blindness.

• Since you study gene expression of renin, I would recommend using the human gene symbol REN for renin instead of the protein name.

We replaced "renin" or "human renin" with REN in the manuscript.

 

1\. Nieuwenhuis S, Forstmann BU, Wagenmakers EJ. Erroneous analyses of interactions in neuroscience: a problem of significance. Nat Neurosci. 2011;14(9):1105-7.

2\. Soufi M, Ruppert V, Rinné S, Mueller T, Kurt B, Pilz G, et al. Increased KCNJ18 promoter activity as a mechanism in atypical normokalemic periodic paralysis. Neurol Genet. 2018;4(5):e274-e.

10.1371/journal.pone.0235530.r003

Decision Letter 1

Kestler

Hans A

Academic Editor

© 2020 Hans A Kestler

2020

Hans A Kestler

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

20 Feb 2020

PONE-D-19-26748R1

Decipher the complexity of cis-regulatory regions by a modified Cas9

PLOS ONE

Dear Mr. Kirchner,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

Reviewer \#2: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: I Don\'t Know

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: (No Response)

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: I thank the authors for reworking their manuscript in accordance with the comments made in my previous review! Most of my suggestions and comments have been included, though some issues remain.

Major comments:

1\. Trans-regulatory elements and their function are not described, only mentioned in context of experimental setup. Please describe their basic function and occurrance in the introduction.

2\. Providing the R-Source-Code in the Supplementary Materials is not a valid substitution for the description of model choice, the modelling processes and validation, and the experiments done on then. Without a detailed description of the models (etc.) no clear evaluation of the data in your manuscript can be made.

\- Please provide sources stating that independent models are indeed a valid way to describe multifactor variables on an output factor, and describe why you decided on this model type.

\- Instead of mentioning the R functions used in the script, describe how the fitting was done, how the random samples were generated, which data was used for the models in which way, how the models were evaluated (e.g. the error calculations mentioned in the manuscript), which statistical tests were used and with what parameters and why, and how the experiments were performed.

\- Cite R and the packages used.

\- Describe all of the above in the manuscript in a manner as to be reproducible by potential readers, without them having to use the provided R-Script.

3\. Regarding the previous major comment 7 of mine, there are still some questions which are left unanswered. Please answer them and include the answers in the manuscript:

Is the activation level of Renin by guide A comparable to biological activation of Renin? Can you be sure that the activation ability of guide A is representative for all the other guides? Without knowing this basing the concentration of all other guides on guide A seems somehow random to me. What was your reasoning for this?

4\. Please provide citations for the hypotheses and assumptions in the discussion section.

Minor comments:

5\. In the Manuscript, there are instances where references were not found and are included in the text in the form of \"Error! Reference source not found.\". Please revise the sourcing in your manuscript.

6\. Some of the figure descriptions do not fit the new figures anymore.

7\. American and British English are still mixed. Please review the manuscript again regarding this.

Reviewer \#2: The manuscript has improved. However, not all the comments made previously have been adequately addressed. In general, it is not enough to answer the raised questions within the answer to the reviewer. Please include these previous raised issues in the manuscript.

Especially, I miss in the discussion a comparison of the applied model type to other available models as well as an explanation for the impact of your findings on the RAAS system and related diseases. Please compare your findings with the current knowledge and the outcome of other studies.

The model setup and statistical analyses are still not sufficiently described.

It is not enough to show a R Code that lacks detailed model representations. Based on the given data, it is infeasible to get even a rudimentary understanding of the models. I would expect an overview of the models and a brief explanation about their establishment.

Furthermore, te added part within the introduction does not help to understand the model type at all.

Different statistical tests were applied (e.g. Wilcoxon and ANOVA) without naming them in the method section. If a p-value is given in the results, it should be clear which test was used to calculate it.

I miss references in the discussion that support the assumptions. Likewise, the method section misses references for the applied R packages as well as for R on its own.

In the discussion and not in the method section, I learned that you used the guides with the best score. What was the scoring threshold?

English was improved, but there is still a huge mix of British and American English through the whole manuscript.

Fig.3: color of the plot is not grey and not blue as stated in the figure legend.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0235530.r004

Author response to Decision Letter 1

4 Apr 2020

Dear Editor,

thank you for reviewing the revised article and for the opportunity to submit a further revised version of the manuscript. We have answered all the questions the reviewers have raised. Especially, we have revised the introduction section and have now addressed the points raised in more detail. In addition, the discussion was reorganized and the points raised were added. Further, we have given more detail about the modelling approach and the statistical evaluation.

 

Reviewer \#1:

I thank the authors for reworking their manuscript in accordance with the comments made in my previous review! Most of my suggestions and comments have been included, though some issues remain.

Major comments:

1\. Trans-regulatory elements and their function are not described, only mentioned in context of experimental setup. Please describe their basic function and occurrence in the introduction.

Thank you for raising this point. For more understanding we added the following paragraph to the manuscript:

"... In addition to the cis-regulatory elements, the transcription factors (TFs) are essential to enable gene transcription. These proteins bind to DNA and can activate or repress the transcription of genes. There are differences in the way TFs act to regulate gene expression. Some TFs need to assemble with other proteins, others can directly recruit RNA polymerase which then leads to gene transcription \[1\]. In a current review, a distinction is made between approx. 1600 human TFs, which represent \~8% of all human genes \[2\]. There are several ways to divide TFs. In general, a division into basal or general TFs and specific transcription factors is possible. Basal TFs are ubiquitous in all cells and necessary for transcription to occur \[3\]. By assembling they a part of the preinitiation complex that enables the binding of the RNA polymerase and thus the initiation of the transcription via specific DNA binding sites such as TATA boxes \[3, 4\]. In contrast, specific transcription factors are active only in specific tissues and/or at specific developmental stages. They may bind at specific DNA binding sites (cis-regulatory regions), e.g. promoters, enhancers or silencers and are necessary for the regulation of central mechanisms such as cell development or the response to stimuli via signal cascades \[5, 6\]. ..."

 

2\. Providing the R-Source-Code in the Supplementary Materials is not a valid substitution for the description of model choice, the modelling processes and validation, and the experiments done on them. Without a detailed description of the models (etc.) no clear evaluation of the data in your manuscript can be made.

Thank you for raising this point. in order to clarify this, we provide now all the steps and the formulas in the text in order to describe the models independent of the source code. (see also below):

Please provide sources stating that independent models are indeed a valid way to describe multifactor variables on an output factor, and describe why you decided on this model type

Thank you for raising this point. We have now included a reference addressing this issue of independence and interaction in biological context in the manuscript \[7\].

Regarding the deeper description of the models we have added for instance the following paragraph in the appropriate sections in the manuscript:

"... When statistically examining factors influencing a variable, it is of general scientific interest to find out whether these factors act independently or interdependently. In our opinion, this question of complex interactions was given too little importance in the research on cis-regulatory regions of REN, especially on the proximal promoter \[8, 9\]. A study that attempted to address this problem with a modelling approach emerged in 2007 \[10\]. But even here the experiments were plasmid-based and therefore outside of the endogenous context. In addition, a regulatory region of REN was in the focus, which is approximately 14 kbp upstream of the start of the transcription.

With this study we want to show on the one hand a novel approach to investigate interactions of cis-regulatory regions in an endogenous context, and on the other hand to raise awareness of how important these interactions are for the interpretation of the importance for the transcriptional regulation.

To study possible complex interactions within the proximal promoter region of REN we applied a novel combined approach. Firstly, this approach consists of combinatorial transfections from five selected guide-RNAs that translocate the SAM-complex to a specific region of the endogenous proximal promoter. The resulting expression levels of REN through the different combinations of the targeted promoter regions can be quantified by a luciferase activity. Secondly, we generated and fitted two different mathematical models to our experimental data. When modelling experimental data, the principle of simplicity should always be considered. The simplest assumption would be that the regions examined influence the expression of REN completely independently of one another. This is reflected in our first model (sum model). The sum model describes an independent relationship of the promoter sequences we examined to their influence on the activation of REN. In this model each individual region is analyzed in respect to its influence on gene expression. This approach is comparable to the knowledge that classic promoter studies can provide, since, as described above, these do not allow the possibility of studying complex interactions. But, an important scientific question in modelling is as to whether there exists statistical interaction \[7\]. In order to address this issue, a second mathematical model was generated (interaction model). This model represents a more complex assumption of the conditions in the region of the proximal promoter. The interaction model additionally allows interactions between the selected promoter regions to explain the REN activation. Regarding modelling we used a multiple linear regression model to fit the linear parameters, which is a standard statistical method. In order to check which of the generated models can best explain the measured data, the respective absolute prediction error was calculated. Following the principle of maximum parsimony in modelling, the respective Akaike information criterion (AIC) was calculated for further model judging."... For the independent sum model, the measured activity y_i can be represented by formula 1:

y_i=∈\_i+β_0+A_i β_1+B_i β_2+C_i β_3+D_i β_4+E_i β_5 ..."

where β_0 is the offset, β\_(1...5) are the linear coefficients, A_i...E_i are {0,1} depending on presence in experiment i and ∈\_i is the error.

"... For the interaction model, the measured activity y_i for all the 32 possible combinations can be represented by formula 2:

y_i=∈\_i+β_0+β_1 A_i+β_2 B_i+β_3 C_i+β_4 D_i+β_5 E_i+β_6 A_i B_i+β_7 A_i C_i+β_8 B_i C_i+β_9 A_i D_i+β_10 B_i D_i+β_11 C_i D_i+β_12 A_i E_i+β_13 B_i E_i+β_14 C_i E_i+β_15 D_i E_i+β_16 A_i B_i C_i+β_17 A_i B_i D_i+β_18 A_i C_i D_i+β_19 B_i C_i D_i+β_20 A_i B_i E_i+β_21 A_i C_i E_i+β_22 B_i C_i E_i+β_23 A_i D_i E_i+β_24 B_i D_i E_i+β_25 C_i D_i E_i+β_26 A_i B_i C_i D_i+β_27 A_i B_i C_i E_i+β_28 A_i B_i D_i E_i+β_29 A_i C_i D_i E_i+β_30 B_i C_i D_i E_i+β_31 A_i B_i C_i D_i E_i

where β_0 is the offset, β\_(1...31) are the linear coefficients, A_i...E_i are {0,1} depending on presence in experiment i and ∈\_i is the error.

 

Instead of mentioning the R functions used in the script, describe how the fitting was done, how the random samples were generated, which data was used for the models in which way, how the models were evaluated (e.g. the error calculations mentioned in the manuscript), which statistical tests were used and with what parameters and why, and how the experiments were performed

Thank you for raising this point. To clarify this the following text has been added to the manuscript:

"... For fitting of the models represented in formula 1 and 2 the fitting functionality of the lm function of the built-in stats package of R version 1.1.423 was used \[11\]. The idea behind this is to minimize the error in prediction of y by optimizing the linear factors β for the experimental data. The lm function of the R package stats computes the linear factors β that fit the input variables A to E according to the proposed model including all the statistics of the fitted parameters. The complete data that was used including the R-script can be found in the supplementary material (S2 R-Script). Data was analyzed at 60 hours after transfection.

For the evaluation of the models we used the obtained coefficients of the respective model and put the coefficients in formula 1 and 2 respectively. For statistical analysis of the coefficients itself the built-in p-value calculation of the multiple linear regression of the lm function of R was used. For comparison of the models we calculated the respective absolute prediction errors of the two models with the built-in predict function of the stats package of R \[11\]. After fitting of the linear factors β, the error ∈\_i could be calculated for the experiments i through conversion of the respective formula. The distribution of the errors of the individual experiments are shown in Fig 7. For statistical analysis of the respective absolute prediction errors we used the independent 2-group Mann-Whitney U Test \[11\]. To compare and to judge the generated models following the principle of maximum parsimony in modelling, the AIC (Akaike Information Criterion) of each model were calculated for further model judging. The AIC was calculated in the R environment with the AIC function of the stats package \[11\].

Random controls were generated by the built-in sample function of R \[11\]. For this purpose, a dataset was created by randomizing the values of the respective variables A to E. This randomized data was then fitted to model 1 and 2 and no statistically significant p values for the coefficients were obtained in the random case. (S2 R-script)

The entire statistical evaluation in the form of model fitting and model evaluation by the 2-group Mann-Whitney U Test of the respective prediction errors and calculation of the AIC did not need any further parameters, apart from the experimental parameters such as incubation temperature or evaluation at about 60 hours after transfection. ..."

Cite R and the packages used.

In the new version of the manuscript we have cited R, R packages and the appropriate used functions.

Describe all of the above in the manuscript in a manner as to be reproducible by potential readers, without them having to use the provided R-Script.

Thank you for raising this point. We are confident that with the improved version of the manuscript a reader can now replicate the analysis with the information given above without the R script in the supplement.

3\. Regarding the previous major comment 7 of mine, there are still some questions which are left unanswered. Please answer them and include the answers in the manuscript:

Is the activation level of Renin by guide A comparable to biological activation of Renin?

Thank you for raising this point. We added the following paragraph to the manuscript:

"... In a previous unpublished study, we have determined the sensible range of guide RNA for renin expression after activation of this promoter region. We were able to show that the protein renin was present in the supernatant of the cell culture. This suggests that we operate in a biologically sensible range of renin expression. Further it shows that secreted renin (biologically relevant for blood pressure regulation) was produced in our cells. ..."

Can you be sure that the activation ability of guide A is representative for all the other guides? Without knowing this basing the concentration of all other guides on guide A seems somehow random to me. What was your reasoning for this?

Thank you for raising this point. We added the following paragraphs to the appropriate section of the manuscript:

"...From those previous studies including studies of other genes in our lab we have found that concentrations of approx. 30 ng per well (of a 96 well plate) of guide RNAs showed a biologically relevant expression of RNA and protein. That is why we have decided to use the concentration of 30 ng per well for transfection in our combinatorial setup in this study. ..."

In order not to confuse the reader we removed figure 2 from the manuscript.

The determination of the activation ability of the individual promoter regions can be estimated by the resulting expressing levels of the experiments in which the guides were transfected individually. The different measured values for the individual transfections can depend not only on the possible different activation ability but also on other factors that were not considered in this work. For example, the regions examined can be occupied by other TFs. A special secondary structure of the DNA or the arrangement of the nucleosomes can also make the access to the SAM complex more difficult \[12\].

4\. Please provide citations for the hypotheses and assumptions in the discussion section.

Thank you for raising this point. We revised the discussion section and added citations to support our assumptions, for instance:

"... 99% decrease in the transcriptional activity of renin was also found when the region of the proximal promoter was deleted in reporter assays performed in As4.1 cells \[9\]. ..."

"... Most of the knowledge about the importance of cis-regulatory areas of the REN is based on this type of promoter studies \[8, 13\]. ..."

"... whether there are interactions within cis-regulatory regions should be a central question in the research of the complex transcriptional network \[7\]. ..."

"... This is another great advantage over classical reporter studies, as they do not allow investigation in an endogenous context \[14-19\]. ..."

Minor comments:

5\. In the Manuscript, there are instances where references were not found and are included in the text in the form of \"Error! Reference source not found.\". Please revise the sourcing in your manuscript.

Sorry for this technical issue and thank you for raising this point. We thoroughly revised the manuscript in order to avoid such errors.

6\. Some of the figure descriptions do not fit the new figures anymore.

Thank you for raising this point. We thoroughly revised the captions of the figures in the new manuscript.

7\. American and British English are still mixed. Please review the manuscript again regarding this.

Thank you for raising this point. The manuscript was again revised by another native speaker in order to improve language and to avoid a mix of American and British English.

 

Reviewer \#2: The manuscript has improved. However, not all the comments made previously have been adequately addressed. In general, it is not enough to answer the raised questions within the answer to the reviewer. Please include these previous raised issues in the manuscript.

Thank you for raising this point. We thoroughly revised the manuscript and answered all the comments made previously. We also added the answers of the previously raised questions to the new manuscript. We would like to address the following previous issue again at this point:

In figure 2 you show the molecular ratio of guide A to achieve maximal luciferase activity. Do these concentration levels also correspond to luciferase activity after transfection with the other guides B-E? If not, what is the explanation?

Thank you for raising this point. We added the following paragraph to the manuscript:

"... We have not performed a concentration dependent analysis for each individual guide in this study. From other studies of other genes in our lab we have used similar concentrations for transfection of guide RNAs that showed biological relevant expression of RNA and protein. That is why we have used the concentration of 30 ng per well for transfection in the combinatorial setup. ..."

In order not to confuse the reader we removed figure 2 from the manuscript.

The determination of the activation ability of the individual promoter regions can be estimated by the resulting expressing levels of the experiments in which the guides were transfected individually. The different measured values for the individual transfections can depend not only on the possible different activation ability but also on other factors that were not considered in this work. For example, the regions examined can be occupied by other TFs. A special secondary structure of the DNA or the arrangement of the nucleosomes can also make the access to the SAM complex more difficult \[12\].

 

Especially, I miss in the discussion a comparison of the applied model type to other available models as well as an explanation for the impact of your findings on the RAAS system and related diseases. Please compare your findings with the current knowledge and the outcome of other studies.

Thank you for raising this point. Most of the outcome of other studies about the cis-regulatory regions of human Renin refer to plasmid-based classical promoter assays, which assume an independent relationship of the investigated regions. This is due to their experimental setup. By design of their studies it cannot be determined whether an interaction occurs. Further, these assays must be performed outside of the endogenous context of the region of interest. To our knowledge our study is the first that addresses this question and beyond in a natural genomic context of a promoter. In that regard our study investigates the cis-regulatory importance of the proximal renin promoter in a more natural setting.

These points can be found now in more detail in the new manuscript.

The model setup and statistical analyses are still not sufficiently described.

It is not enough to show a R Code that lacks detailed model representations. Based on the given data, it is infeasible to get even a rudimentary understanding of the models. I would expect an overview of the models and a brief explanation about their establishment. Furthermore, the added part within the introduction does not help to understand the model type at all.

Thank you for raising this point. We revised the introduction and material and methods sections and added the following paragraphs to get a better understanding of our approach and the reason for generating the two models:

"... When statistically examining factors influencing a variable, it is of general scientific interest to find out whether these factors act independently or interdependently. In our opinion, this question of complex interactions was given too little importance in the research on cis-regulatory regions of REN, especially on the proximal promoter \[8, 9\]. A study that attempted to address this problem with a modelling approach emerged in 2007 \[10\]. But even here the experiments were plasmid-based and therefore outside of the endogenous context. In addition, a regulatory region of REN was in the focus, which is approximately 14 kbp upstream of the start of the transcription.

With this study we want to show on the one hand a novel approach to investigate interactions of cis-regulatory regions in an endogenous context, and on the other hand to raise awareness of how important these interactions are for the interpretation of the importance for the transcriptional regulation.

To study possible complex interactions within the proximal promoter region of REN we applied a novel combined approach. Firstly, this approach consists of combinatorial transfections from five selected guide-RNAs that translocate the SAM-complex to a specific region of the endogenous proximal promoter. The resulting expression levels of REN through the different combinations of the targeted promoter regions can be quantified by a luciferase activity. Secondly, we generated and fitted two different mathematical models to our experimental data. When modelling experimental data, the principle of simplicity should always be considered. The simplest assumption would be that the regions examined influence the expression of REN completely independently of one another. This is reflected in our first model (sum model). The sum model describes an independent relationship of the promoter sequences we examined to their influence on the activation of REN. In this model each individual region is analyzed in respect to its influence on gene expression. This approach is comparable to the knowledge that classic promoter studies can provide, since, as described above, these do not allow the possibility of studying complex interactions. But, an important scientific question in modelling is as to whether there exists statistical interaction \[7\]. In order to address this issue, a second mathematical model was generated (interaction model). This model represents a more complex assumption of the conditions in the region of the proximal promoter. The interaction model additionally allows interactions between the selected promoter regions to explain the REN activation. Regarding modelling we used a multiple linear regression model to fit the linear parameters, which is a standard statistical method. In order to check which of the generated models can best explain the measured data, the respective absolute prediction error was calculated. Following the principle of maximum parsimony in modelling, the respective Akaike information criterion (AIC) was calculated for further model judging. ..."

"... For the independent sum model, the measured activity y_i can be represented by formula 1:

y_i=∈\_i+β_0+A_i β_1+B_i β_2+C_i β_3+D_i β_4+E_i β_5

where β_0 is the offset, β\_(1...5) are the linear coefficients, A_i...E_i are {0,1} depending on presence in experiment i and ∈\_i is the error. ..."

For the interaction model the measured activity y_i for all the 32 possible combinations can be represented by formula 2:

y_i=∈\_i+β_0+β_1 A_i+β_2 B_i+β_3 C_i+β_4 D_i+β_5 E_i+β_6 A_i B_i+β_7 A_i C_i+β_8 B_i C_i+β_9 A_i D_i+β_10 B_i D_i+β_11 C_i D_i+β_12 A_i E_i+β_13 B_i E_i+β_14 C_i E_i+β_15 D_i E_i+β_16 A_i B_i C_i+β_17 A_i B_i D_i+β_18 A_i C_i D_i+β_19 B_i C_i D_i+β_20 A_i B_i E_i+β_21 A_i C_i E_i+β_22 B_i C_i E_i+β_23 A_i D_i E_i+β_24 B_i D_i E_i+β_25 C_i D_i E_i+β_26 A_i B_i C_i D_i+β_27 A_i B_i C_i E_i+β_28 A_i B_i D_i E_i+β_29 A_i C_i D_i E_i+β_30 B_i C_i D_i E_i+β_31 A_i B_i C_i D_i E_i

where β_0 is the offset, β\_(1...31) are the linear coefficients, A_i...E_i are {0,1} depending on presence in experiment i and ∈\_i is the error.

Different statistical tests were applied (e.g. Wilcoxon and ANOVA) without naming them in the method section. If a p-value is given in the results, it should be clear which test was used to calculate it.

Thank you for raising this point. We revised the paragraph "Modelling of received data and statistics" in order to get a better understanding of the generated models and where all the statistics are described.

I miss references in the discussion that support the assumptions.

Thank you for raising this point. We revised the discussion section and added citations to support our assumptions, for instance:

"... 99% decrease in the transcriptional activity of renin was also found when the region of the proximal promoter was deleted in reporter assays performed in As4.1 cells \[9\]. ..."

"... Most of the knowledge about the importance of cis-regulatory areas of the REN is based on this type of promoter studies \[8, 13\]. ..."

"... whether there are interactions within cis-regulatory regions should be a central question in the research of the complex transcriptional network \[7\]. ..."

"... This is another great advantage over classical reporter studies, as they do not allow investigation in an endogenous context \[14-19\]. ..."

 

Likewise, the method section misses references for the applied R packages as well as for R on its own.

All the R packages and R functions have been cited in full in the new manuscript.

In the discussion and not in the method section, I learned that you used the guides with the best score. What was the scoring threshold?

We have used the "SAM sgRNA design tool":

<http://sam.genome-engineering.org/database/>

The guides are sorted in order of specificity (highest to lowest) based on method described in Hsu et. al. Nature Biotech 2014 \[20\]. We have chosen to use the top 5 hits for human REN.

We revised the paragraph "REN-guides: Design and Cloning" in the material and methods section in order to make the design understandable.

English was improved, but there is still a huge mix of British and American English through the whole manuscript.

Thank you for raising this point. The manuscript was again revised by another native speaker in order to improve language and to avoid a mix of American and British English.

Fig.3: color of the plot is not grey and not blue as stated in the figure legend.

Thank you for raising this point. We revised the figure captions.
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\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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4 Jun 2020

Dear Editor,

thank you for reviewing the revised article and for the opportunity to submit a further revised version of the manuscript. We thoroughly revised the manuscript and worked on all the points raised by the reviewers. We revised the results section in order to describe the results and figures in more detail. Furthermore, the entire manuscript has now been written in British English.

Yours sincerely

Steven Kirchner

 

Reviewer \#1:

Major comments:

1\. Some parts of the discussion (e.g. the reasoning for the guide-RNA concentrations in lines 468-472) should be moved to the Methods section.

Thank you for raising this point. We thoroughly revised the discussion section and moved the paragraph mentioned into the methods section. While carefully revising the manuscript, we did not notice any other sections that had to be moved to the methods section.

2\. Sample sizes for the transfection and the Luciferase-Reporter-Assays should be mentioned in the methods section.

Thank you for raising this point. We now mention the sample sizes in the respective paragraph.

3\. Is there an analysis on the quality of your laboratory data such as standard deviations of the measurements for the different time points and guide-RNA combinations? If yes, please mention this in the Methods section and the Results section respectively, and also include a table of this data in the manuscript. If no, these analyses should be made and included as described above.

Thank you for raising this point. We added a table to the supporting information section (S2 Table) that shows REN activation represented by means and standard deviations of all 32 combinations at the three different time points.

Minor comments:

1\. Grammar and punctuation should be revised once more.

We apologize that there were still problems with grammar and punctuation in the second revision of the manuscript. We thoroughly revised the manuscript in order address those issues.

2\. The whole manuscript should be uniformly written in British OR American English.

We apologize that there were still problems with the language in the second revision of the manuscript. The whole manuscript should now be written in British English.

3\. The formula for the melting temperature of DNA should be mentioned in-line, not as a separate formula in its own line.

Thank you for raising this point. The formula for the melting temperature of DNA is now mentioned in-line.

 

Reviewer \#2:

1\. Please revise the whole manuscript especially for these two words ("modelling", "analyse"). Furthermore, please check the punctuation.

We apologize that there were still problems with language, grammar and punctuation in the second revision of the manuscript. We thoroughly revised the manuscript in order address those issues. The whole manuscript should now be written in British English.

2\. Line 182-183: Please add a reference for the standard statistical method

Thank you for raising this point. We added the following reference:

Fisher RA. The Goodness of Fit of Regression Formulae, and the Distribution of Regression Coefficients. Journal of the Royal Statistical Society. 1922;85(4):597-612

DOI: 10.2307/2341124

3\. Line 185-186: Please add a reference for AIC

Thank you for raising this point. We added the following reference:

Akaike H. CITATION CLASSIC - A NEW LOOK AT THE STATISTICAL-MODEL IDENTIFICATION. Current Contents/Engineering Technology & Applied Sciences. 1981(51):22-

DOI: 10.1109/TAC.1974.1100705

4\. Remove Fig 7 from the methods. Otherwise you have to change the figure counting.

Thank you for raising this point. We removed "The distribution of the errors of the individual experiments is shown in Fig 7" from the methods section.

5\. Results: Please connect the independently performed experiments with each other. Especially at the beginning line 348-372. It is not clear to the reader why these experiments were done and which conclusions did you draw out of them.

Thank you for raising this point. We thoroughly revised the results section in order to address this issue and to give the reader more details to understand the performed experiments.

6\. Line 364-366: No information content. What is the benefit for the reader to know how many data points were collected?

Thank you for raising this point. We removed the respective sentence from the manuscript.

7\. Line 370-372: Please add here a suggestion/conclusion what does this experiment tells you and do not leave the reader alone with its interpretation.

Thank you for raising this point. We added the following paragraph to the manuscript:

"... In Fig 3 expression levels of the 32 possible combinations are shown at three different time points after transfection using the modified Venn diagram as described above (Fig 2). Respective activation levels of REN were expressed in a colour ramp that rose in ascending order from white to yellow, further to red and up to blue. For analysis, the values of expression levels were scaled logarithmically. Otherwise, since these values were widely divergent, only a few surfaces would have been coloured in a linear scale, whereas most were white to slightly yellow. On the one hand the individual guides itself caused different levels of renin expression. On the other hand, the different combinations achieved different renin activation (Fig 3 and S2 table). The combinations of the two guides C -- B or A -- E caused a renin activation that was higher than the simple summation of the respective individual activation levels. In contrast, combinations of the two guides A -- B or also D -- C have a less increasing effect on the renin activation. ..."

8\. Figure description of Fig S1 is missing.

Thank you for raising this point. We added the following description for Fig S1:

"The cassette contains the Firefly luciferase, which was used as a reporter for REN expression. Puromycin was used to select the cells. The homology arms were required for the correct in frame insertion of the cassette. The elements G418-resistance and thymidine-kinase also contained in the cassette were not used in this study."

9\. Take care about the quality of the figures. They appear blurred

Thank you for raising this point. We followed the instructions of PLOS ONE to upload the figures. It might be that the conversion into pdf reduces the quality of the figures. For a potential production we would have all the pictures available in high quality.

10.1371/journal.pone.0235530.r007
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PONE-D-19-26748R3

Dear Dr. Kirchner,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Hans A Kestler

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: I thank the Authors for their continued work on the manuscript. All of my previous concerns have been addressed.

I have one last minor comment to make:

In Figure 4 \"cps\" is mentioned but it is never explained what this abbreviation means. Please include this information in the Figure text, and please check the rest of the manuscript for more unexplained abbreviations (I might have missed one in my read-through).

Reviewer \#2: The manuscript has improved a lot and is now suitable for publication.

Please correct the below mentioned spelling mistakes:

-line255: add punctuation

-line 269: use \",\" to separate 1000 \--\> 50,000

-line 364: VisualiSation

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No
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PONE-D-19-26748R3

Decipher the complexity of cis-regulatory regions by a modified Cas9

Dear Dr. Kirchner:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Hans A Kestler

Academic Editor

PLOS ONE
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